Novartis | NOVARTIND | NSE - Pharmaceuticals


Performance Valuation Growth Insiders Summary Balance Sheet Income Statement Cash Flow Quarterly
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.
 Chart
2017
2018
2019
2020
2021
Revenue
Revenue
6,5625,6394,9074,3834,144
Cost of revenue
Cost of revenue
-3,061-2,455-1,987-1,823-1,466
Gross Profit
Gross Profit
3,501
3,184
2,920
2,559
2,678
Sales, general & ad...
Sales, general and administrative
-3,242-3,246-2,798-2,439-2,079
Depreciation
Depreciation and amortization
-36-25-32-131-122
Provision
Provision
00000
Other op inc/exp...
Other operating income/expenses
00000
Operating income
Operating income EBIT
223
-88
91
-11
477
 
      
Profit before tax
Profit before tax
9171,575858286400
Net Income
Net income
572
784
518
101
209
 
 
 
 
 
 
 
EPS Basic
EPS Basic in Rupees
19.10
28.43
20.97
4.08
8.46